Company intelligence / Profile preview

Changzhou Xuanming Pharmaceutical Technology

Changzhou, Jiangsu, China

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Changzhou Xuanming Pharmaceutical Technology is a technology-focused pharmaceutical service provider and chemical manufacturer. It specializes in the research, development, and production of pharmaceutical intermediates, pesticide intermediates, and fine chemicals. The company provides custom synthesis and CDMO services to the global market, with a strong focus on high-purity peptides (such as GLP-1 and GIP receptor agonists) and complex small molecule APIs. It operates R&D centers in Beijing, Tianjin, and Jiangsu, with a manufacturing base in Jiangxi Province.

Therapeutic areas: OncologyEndocrinologyImmunology
Modalities: Small moleculePeptides
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Changzhou Xuanming Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changzhou Xuanming Pharmaceutical Technology.

Explore the full profile